The Roxadustat Chronicles: A Two-Article NephJC — NephJC
Roxadustat in clinical trials with CRP. | Download Scientific Diagram
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non–Dialysis-Dependent CKD | American Society of Nephrology
Roxadustat in clinical trials with CRP. | Download Scientific Diagram
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study - American Journal of Kidney
Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study | American Society of Nephrology
Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia | American Society of Nephrology
Key milestones in the development of roxadustat for the treatment of... | Download Scientific Diagram
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study | American Society of Nephrology
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
Frontiers | A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat | Medicine
Safety Concerns Turn FDA Panel Thumbs Down for Novel CKD-Anemia Drug | MedPage Today
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
Clinical trial paper that made anemia drug look safer than it is will be retracted – Retraction Watch
Edgar V. Lerma 🇵🇭 on Twitter: "Roxadustat - 30% lower risk of MACE and 34% lower risk of MACE+ than epoetin alfa & with a trend towards lower all-cause mortality relative to
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis | NEJM
Roxadustat in phase III clinical trials. | Download Scientific Diagram
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement | Semantic Scholar
IJERPH | Free Full-Text | Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future? | HTML
Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis - ScienceDirect
The Roxadustat Chronicles: A Two-Article NephJC — NephJC
Completed Phase 2 and 3 Studies of Roxadustat (FG-4592), Vadadustat... | Download Table
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study - ScienceDirect
Phase 3 clinical trials of Roxadustat. | Download Scientific Diagram
